current treatment

OTHER4 trials

Sponsors

Chugai Pharmaceutical, Oslo University Hospital, Hanmi Pharmaceutical Company Limited, Hospital Central Dr. Ignacio Morones Prieto

Conditions

Aortic RegurgitationAortic StenosisBurnsHip FractureHypertensionLVMLeft Ventricular HypertrophyOther Low-trauma Fracture

Phase 3

Phase III Comparative Study(Open-Label) of MRA for Rheumatoid Arthritis(RA)

CompletedNCT00144508

Chugai PharmaceuticalRheumatoid Arthritis

Start: 2003-03-31End: 2006-02-28Updated: 2009-02-02

Phase 4

Study to Evaluate the Effect on Improvement of LVH by the Control of BP in Hypertension Patients With AV Disease

CompletedNCT03666351

Hanmi Pharmaceutical Company LimitedAortic Regurgitation, Aortic Stenosis, Hypertension +2

Start: 2018-10-18End: 2022-07-25Updated: 2022-09-15

Unknown Phase

Norwegian Capture the Fracture Initiative

CompletedNCT02536898

Oslo University HospitalHip Fracture, Other Low-trauma Fracture, Vertebral Fracture

Start: 2015-05-31End: 2020-05-31Updated: 2022-03-22

Impact of a Clinical Decision Algorithm on Length of Hospital Stay and Costs of Care of Burned Patients

Hospital Central Dr. Ignacio Morones PrietoBurns

Start: 2018-11-01End: 2020-08-31Target: 44Updated: 2020-02-13

Related Papers

Effects of intensive blood pressure control on left ventricular hypertrophy in aortic valve disease.

2023-11-231 citations

Effect of a Fracture Liaison Service on the Rate of Subsequent Fracture Among Patients With a Fragility Fracture in the Norwegian Capture the Fracture Initiative (NoFRACT)

JAMA Network Open2018-12-0726 citations